Material Agreements

DIGITAL REALTY TRUST, INC. entered into 3.750% Guaranteed Notes due 2033 and 4.250% Guaranteed Notes due 2037 (Euro Notes) with Deutsche Trustee Company Limited, Deutsche Bank AG, London Branch, Deutsche Bank Luxembourg S.A. valued at €600,000,000 of 3.750% Notes due 2033; €800,000,000 of 4.250% Notes due 2037; net proceeds ~€1,384.7 (effective 2025-11-20).

“On November 20, 2025, Digital Euro Finco, LLC, a wholly owned indirect finance subsidiary of the operating partnership, issued and sold €600,000,000 aggregate principal amount of 3.750% Guaranteed Notes due 2033 denominated in Euros (the “2033 Notes”) and €800,000,000 aggregate principal amount of 4.250% Guaranteed Notes due 2037 denominated in Euros (the “2037 Notes” and together with the 2033 Notes, the “Euro Notes”).”

abrdn Global Dynamic Dividend Fund entered into Distribution Agreement with ALPS Distributors, Inc. valued at up to $25,000,000 (effective 2025-11-21).

“On November 21, 2025, abrdn Global Dynamic Dividend Fund (NYSE: AGD) (the “Fund”) entered into a distribution agreement (the “Distribution Agreement”) with ALPS Distributors, Inc. (the “Distributor”), pursuant to which the Fund may offer and sell up to $25,000,000 of common shares of beneficial interest with no par value (“Common Shares”), from time to time through the Distributor, in transactions deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Offering”).”

Tonix Pharmaceuticals Holding Corp. amended Sales Agreement with A.G.P./Alliance Global Partners (effective 2025-11-21).

“On November 21, 2025, Tonix Pharmaceuticals Holding Corp. (the “Company”) amended its Sales Agreement with A.G.P./Alliance Global Partners, dated as of June 11, 2025 (as amended, the “Sales Agreement”), to allow for an increase to the maximum aggregate offering price of shares issuable under the Sales Agreement (the “Amendment”).”

XMax Inc. entered into Convertible Promissory Note Purchase Agreement with Billiongold Holding Limited valued at $5,000,000 (effective 2025-11-18).

“On November 18, 2025, XMax Inc., a Nevada company (the “Company”), entered into a Convertible Promissory Note Purchase Agreement (the “Agreement”) with Billiongold Holding Limited, a company incorporated under the law of Hong Kong (the “Purchaser”).”

Adverum Biotechnologies, Inc. terminated Original Lease with ARE-NC Region No. 21 LLC valued at $0.1 million (effective 2025-11-19).

“On November 20, 2025, ARE-NC Region No. 21 LLC, a Delaware limited liability company (the “Landlord”), delivered to Adverum Biotechnologies, Inc. (the “Company”) and Adverum NC, LLC, a notice of termination (the “Termination Notice”) of that certain Lease Agreement, dated January 8, 2021, as amended (the “Original Lease”), for the Company’s premises located at 14 TW Alexander Drive, Durham, North Carolina. Pursuant to the Notice, the Original Lease was terminated as of November 19, 2025.”

Moody National REIT II, Inc. entered into Agreement of Purchase and Sale with Alay Investment Group LLC valued at $8,400,000 (effective 2025-11-17).

“On November 17, 2025, subsidiaries of Moody National REIT II, Inc. (the “Company”) entered into an Agreement of Purchase and Sale (the “Sale Agreement”) with Alay Investment Group LLC, a Texas limited liability company unaffiliated with the Company (the “Purchaser”). Pursuant to the Sale Agreement, the Company has agreed, subject to the terms and conditions of the Sale Agreement, to sell all of the Company’s rights and interests in the hotel property located at 29813 Interstate 45, Spring, Texas 77381 (the “Houston Property”) to the Purchaser for an aggregate purchase price of $8,400,000, subject to certain customary offsets and credits thereto as set forth in the Sale Agreement.”

TPG RE Finance Trust, Inc. entered into FL7 Indenture with TRTX 2025-FL7 Issuer, Ltd., TRTX 2025-FL7 Co-Issuer, LLC, TRTX Master CLO Loan Seller, LLC, Wilmington Trust, National Association, Computershare Trust Company, National Association valued at $616,000,000 aggregate principal amount of Class A Senior Secured Floating Rate Notes Due 2043 (effective 2025-11-17).

“the FL7 Issuers co-issued the following classes of notes pursuant to the terms of an indenture, dated as of November 17, 2025 (the “FL7 Indenture”), by and among the FL7 Issuers, TRTX Master CLO Loan Seller, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (the “FL7 Seller”), as advancing agent, Wilmington Trust, National Association, as trustee (together with its permitted successors and assigns, the “FL7 Trustee”), and Computershare Trust Company, National Association, as note administrator, paying agent, calculation agent, authenticating agent, transfer agent, custodian, backup advancing agent and notes registrar (in all such capacities, together with its permitted successors and assigns, the “FL7 Note Administrator”):”

International Land Alliance Inc. entered into Maintenance Agreement with Mast Hill Fund L.P. valued at $5,209,000 (effective 2025-11-17).

“b. Maintenance Agreement (attached as Exhibit 10.4) pursuant to which Company shall provide certain property maintenance services to a facility (the "Facility") affiliated with Mast Hill for monthly service fees until June 22, 2044 in the amount equal to: gross rental income from the Facility from the immediately preceding calendar month, minus customary fees, expenses, and maintenance reserves.”

International Land Alliance Inc. entered into Securities Purchase Agreement with Mast Hill Fund L.P. valued at $50,000,000 (effective 2025-11-17).

“On November 17, 2025, International Land Alliance, Inc., a Wyoming corporation (the "Company") entered into a transaction with Mast Hill Fund L.P. ("Mast Hill") with the following agreements: a. Securities Purchase Agreement (attached hereto as Exhibit 10.1), pursuant to which the Company issued to Mast Hill a Convertible Promissory Note in the aggregate principal amount up to $50,000,000 ("Mast Hill Note" attached hereto Exhibit 10.2).”

BeyondSpring Inc. entered into Purchase Agreement with Ray Beauty Group Limited valued at $2.0 million (effective 2025-11-17).

“On November 17, 2025, BeyondSpring Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Ray Beauty Group Limited (the “Investor”), pursuant to which the Company agree to issue and sell, in a registered offering, an aggregate of 800,000 shares of the Company’s ordinary shares, par value $0.0001 per share (the “Shares”), at a purchase price of $2.50 per share (the “Transaction”).”

Catheter Precision, Inc. terminated At-Market-Offering Agreement with Ladenburg Thalmann & Co. Inc. (effective 2025-11-17).

“On November 17, 2025, Catheter Precision, Inc. (the “Company”) delivered notice to terminate its At-Market-Offering Agreement (the “ATM Agreement”), dated as of May 19, 2025, with Ladenburg Thalmann & Co. Inc. (the “Agent”) providing for the Company’s “at‐the‐market” equity offering program (the “ATM Program”), to be effective as of November 24, 2025.”

Synchrony Card Funding, LLC entered into Class A(2025-3) Terms Document with The Bank of New York Mellon, as Indenture Trustee (effective 2025-11-17).

“On November 17, 2025, Synchrony Card Issuance Trust (the “ Trust ”) and The Bank of New York Mellon, as Indenture Trustee (the “ Indenture Trustee ”), entered into the Class A(2025-3) Terms Document (the “ Class A(2025-3) Terms Document ”).”

Inhibikase Therapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC, BofA Securities, Inc. and Cantor Fitzgerald & Co., as representatives of the several underwriters (effective 2025-11-20).

“On November 20, 2025, Inhibikase Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, BofA Securities, Inc. and Cantor Fitzgerald & Co., as representatives of the several underwriters listed on Schedule A thereto (collectively, the “Underwriters”), relating to an underwritten public offering (the “Offering”) of (i) 46,091,739 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and (ii) in lieu of Common Stock to certain investors, pre-funded warrants to purchase up to an aggregate of 22,873,779 shares of Common Stock (the “Pre-Funded Warrants” and the Common Stock issuable upon exercise of the Pre-Funded Warrants, the “Warrant Shares”).”

Shuttle Pharmaceuticals Holdings, Inc. entered into release and settlement agreement between Company and Theradex Systems, Inc. with Theradex Systems, Inc. valued at partial payment of $300,000; release of Outstanding Liabilities of approximately $557,000; Company e (effective 2025-11-20).

“Pursuant to the notice of termination, on November 20, 2025, the Company and Theradex entered into a release and settlement agreement (the “Settlement Agreement”), pursuant to which the Company will pay a partial payment of $300,000 to Theradex as full and final payment of any and all claims relating to the debt or obligation previously owed by the Company to Theradex, totalling approximately $557,000 (the “Outstanding Liabilities”) and in consideration of such payment, each party will release, acquit and discharge each other from all claims arising from the Outstanding Liabilities and Theradex will properly wind down the Clinical Trials (as defined below) in a manner compliant with the Food and Drug Administration.”

Shuttle Pharmaceuticals Holdings, Inc. terminated master agreement between Shuttle Pharmaceuticals, Inc. and Theradex Systems, Inc. with Theradex Systems, Inc. valued at Outstanding Liabilities of approximately $557,000; partial payment of $300,000; remaining research s (effective 2025-10-15).

“As previously disclosed by the Company in its Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 21, 2025, on October 15, 2025, Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) received a letter from Theradex Systems, Inc. (“Theradex”), providing written notice of termination of the master agreement, dated November 1, 2018 (the “Master Agreement”), between Shuttle Pharmaceuticals, Inc. (the Company’s wholly-owned subsidiary) and Theradex, and all work orders thereunder.”

OneWater Marine Inc. amended Third Amendment to Eighth Amended and Restated Inventory Financing Agreement, Omnibus Amendment to Collateralized Guarantees, and First Amendment to Consent Agreement with unknown valued at Modified termination date to March 1, 2027, adjusted maximum borrowing capacity to $497.1 million, a (effective 2025-11-17).

“On November 17, 2025, the Company entered into the Third Amendment to Eighth Amended and Restated Inventory Financing Agreement, Omnibus Amendment to Collateralized Guarantees, and First Amendment to Consent Agreement (the "Third Amendment") to, among other things, (i) modify certain definitions, covenants, terms and conditions, (ii) modify the termination date of the Third Agreement to be March 1, 2027, and (iii) adjust the maximum borrowing capacity to $497.1 million and permit an additional $38.7 million in availability for overtrade capacity.”

OneWater Marine Inc. amended Amendment No. 7 to Amended and Restated Credit Agreement and Amendment to Pledge and Security Agreement with unknown valued at Modified maturity date to July 31, 2027, and adjusted applicable interest rates. (effective 2025-11-17).

“On November 17, 2025, OneWater Marine Inc. (the “Company”) entered into Amendment No. 7 to Amended and Restated Credit Agreement and Amendment to Pledge and Security Agreement ("Amendment No.7") to, among other things, (i) modify certain definitions, covenants, terms and conditions and (ii) modify the maturity date to be July 31, 2027, and in connection therewith, the repayment schedule, including certain adjustments to applicable interest rates.”

Cullinan Therapeutics, Inc. terminated Exclusive Patent License Agreement with Massachusetts Institute of Technology (MIT) valued at termination effective February 18, 2026; return of licensed patent rights for CLN-617 (effective 2026-02-18).

“On November 18, 2025, in connection with its decision not to pursue further development of CLN-617, Cullinan Amber Corp. (the "Company"), a subsidiary of Cullinan Therapeutics, Inc. notified Massachusetts Institute of Technology ("MIT") of its decision to terminate the Exclusive Patent License Agreement, dated December 20, 2019 between the Company and MIT, as amended from time to time (the "License Agreement"), effective as of February 18, 2026.”

Opendoor Technologies Inc. entered into Warrant Agreement with Equiniti Trust Company, LLC (effective 2025-11-21).

“Warrant Agreement, dated as of November 21, 2025, between the Company and Equiniti Trust Company, LLC, as Warrant Agent (the “Warrant Agreement”)”

Tango Therapeutics, Inc. terminated Open Market Sales Agreement SM (Jefferies Sales Agreement) with Jefferies LLC valued at termination of the 2022 ATM Program under which the Company could sell up to $100,000,000 of shares (effective 2025-11-21).

“On November 18, 2025, the Company delivered written notice to Jefferies to terminate the Jefferies Sales Agreement, effective as of November 21, 2025, pursuant to Section 7(b)(i) thereof.”

Tango Therapeutics, Inc. entered into Sales Agreement with Leerink Partners LLC valued at up to $100,000,000 of shares of common stock (effective 2025-11-21).

“On November 21, 2025, Tango Therapeutics, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Leerink Partners LLC (the “Agent”), pursuant to which the Company may sell, from time to time, at its option, shares of the Company’s common stock, $0.001 par value per share (the “Shares”), through the Agent, as sales agent (the “ATM Offering”).”

BioAtla, Inc. entered into Standby Equity Purchase Agreement with YA II PN, Ltd. valued at Standby Equity Purchase Agreement (effective 2025-11-20).

“Also on November 20, 2025 (the “Effective Date”), the Company entered into the Standby Equity Purchase Agreement (the “SEP”

BioAtla, Inc. entered into Pre-Paid Advance Agreement with YA II PN, Ltd.; Anson Investments Master Fund LP; Anson East Master Fund LP valued at $7.5 million Pre-Paid Advance; gross proceeds of approx. $7.13 million (effective 2025-11-20).

“On November 20, 2025, BioAtla, Inc. (the “Company”) entered into Pre-Paid Advance Agreements (the “PPAs”) with each of YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”), Anson Investments Master Fund LP and Anson East Master Fund LP (collectively, the “Investors”).”

Nuvve Holding Corp. entered into Additional Note with a certain Investor valued at $277,777.00 (effective 2025-11-17).

“on November 17, 2025, the Company issued to a certain Investor (i) a $277,777.00 principal amount (the “Principal Amount”) senior convertible promissory note”

Healthcare Triangle, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $6,000,000 (effective 2025-11-20).

“On November 20, 2025, Healthcare Triangle, Inc., a Delaware corporation, (the “Company”), entered into a Securities Purchase Agreement (“Purchase Agreement”) with certain institutional investors (the “Investors”).”

DEEP FISSION, INC. entered into Agreement with United States Department of Energy (effective 2025-11-14).

“the Company and the United States Department of Energy fully executed and delivered an Other Transaction Agreement for Reactor Authorization, effective as of November 14, 2025, which we refer to as the “Agreement””

Lord Abbett Private Credit Fund amended Second Amendment with Bank of America, N.A. valued at increase to the maximum committed amount from $400,000,000 to $450,000,000 (effective 2025-11-18).

“On November 18, 2025, Lord Abbett PCF Financing LLC (“PCF Financing”), a wholly-owned, special purpose financing subsidiary of Lord Abbett Private Credit Fund (the “Company”), entered into the Second Amendment (the “Second Amendment”) to the Credit Agreement (the “Credit Agreement”), dated January 23, 2025, by and among PCF Financing, as borrower, the Company, as servicer, Bank of America, N.A. (“Bank of America”), as administrative agent (in such capacity “Administrative Agent”) and sole lead arranger and sole book manager, each of the lenders from time to time party thereto, and State Street Bank and Trust Company, as collateral custodian.”

ENVIRI Corp entered into Separation Agreement with Veolia Environnement S.A. (effective 2025-11-20).

“a Separation Agreement, dated as of November 20, 2025 (the “Separation Agreement”), by and among the Corporation, CLEH, Buyer, and Enviri II Corporation, a newly formed Delaware corporation and a direct wholly owned subsidiary of the Corporation (“New Enviri”)”

ENVIRI Corp entered into Agreement and Plan of Merger with Veolia Environnement S.A. (effective 2025-11-20).

“Agreement and Plan of Merger, dated as of November 20, 2025 (the “Merger Agreement”), by and among the Corporation, CLEH, Inc., a newly formed Delaware corporation and a direct wholly owned subsidiary of the Corporation (“CLEH”), Enviri LLC, a Delaware limited liability company and a direct wholly owned subsidiary of CLEH (“Enviri LLC”), Buyer, and Liberty Merger Sub Inc., a Delaware corporation and wholly owned indirect subsidiary of Buyer (“Merger Sub”)”

DYCOM INDUSTRIES INC entered into Unit Purchase Agreement with Project Eastern Shore, LLC and Power Solutions, LLC valued at $1,950,000,000 (effective 2025-11-18).

“On November 18, 2025, Dycom Industries, Inc., a Florida corporation (the “ Dycom ”) entered into a Unit Purchase Agreement (the “ Purchase Agreement ”) with Project Eastern Shore, LLC, a Maryland limited liability company (the “ Seller ”), and Power Solutions, LLC, a Maryland limited liability company (“ Company ”), pursuant to which, upon the terms and subject to the conditions set forth therein, Dycom will acquire from the Seller all of the outstanding units of the Company”

SERVICE CORP INTERNATIONAL entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and certain other financial institutions, as lenders valued at $750 million senior term loan facility, maturing in November 2030, and a revolving credit facility p (effective 2025-11-20).

“On November 20, 2025, Service Corporation International (the “Company”) entered into a new senior unsecured credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, and certain other financial institutions, as lenders, providing for a $750 million senior term loan facility, maturing in November 2030 (the “Term Loan A”), and a revolving credit facility providing for borrowings of up to $1.75 billion, with commitments expiring and loans maturing in November 2030 (the “Revolving Facility” and, together with the Term Loan A, the “Credit Agreement”).”

PARKERVISION INC entered into Subscription Agreements with accredited investors valued at approximately $3,461,132 (effective 2025-11-21).

“On November 21, 2025, ParkerVision, Inc. (the “ Company ”) entered into subscription agreements (the “ Subscription Agreements ”) with accredited investors (the "Investors") pursuant to which the Investors agreed to purchase an aggregate of 16,481,579 shares of the Company’s common stock, par value $0.01 per share (“ Common Stock ”), at a purchase price of $0.21 per share, for an aggregate purchase price of approximately $3,461,132.”

TRANSCAT INC amended Second Amendment with John Cummins and Ross Lane (effective 2024-05-20).

“On May 20, 2024, Transcat, Inc. (the “Company”) entered into an amendment (the “Second Amendment”) to a Share Purchase Agreement dated August 31, 2021 (the “Purchase Agreement”) with John Cummins and Ross Lane (the “Sellers”)”

INSIGHT ENTERPRISES INC entered into Indenture with U.S. Bank Trust Company, National Association valued at $500 million (effective 2024-05-20).

“The Notes were issued pursuant to an Indenture, dated as of May 20, 2024 (the “Indenture”), among the Company, the Guarantors and U.S. Bank Trust Company, National Association, as trustee.”

SITE Centers Corp. entered into Purchase Agreement with an affiliate of Pine Tree valued at $495 million (effective 2024-05-17).

“On May 17, 2024, certain subsidiaries (the " Sellers ") of SITE Centers Corp. (the " Company ") entered into a Purchase Agreement (the " Purchase Agreement ") with an affiliate of Pine Tree (the " Purchaser "). Pursuant to the Purchase Agreement, the Sellers have agreed to sell to the Purchaser their interests in Arrowhead Crossing (Phoenix, Arizona), Easton Market (Columbus, Ohio), The Fountains (Miami, Florida), Kenwood Square (Cincinnati, Ohio), Polaris Towne Center (Columbus, Ohio) and Tanasbourne Town Center (Portland, Oregon) for a price of $495 million in cash, subject to adjustment for certain closing pro-rations, allocations and credits for signed leases and capital expenditures.”

SouthState Bank Corp entered into Agreement and Plan of Merger with Independent Bank Group, Inc. (effective 2024-05-17).

“On May 17, 2024, SouthState Corporation, a South Carolina corporation (“SouthState”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Independent Bank Group, Inc., a Texas corporation (“IBTX”).”

OVERSEAS SHIPHOLDING GROUP INC entered into Merger Agreement with Saltchuk Resources, Inc. and Seahawk MergeCo., Inc. (effective 2024-05-19).

“On May 19, 2024, Overseas Shipholding Group, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Saltchuk Resources, Inc. (“Saltchuk”) and Seahawk MergeCo., Inc., a wholly owned subsidiary of Saltchuk (“Merger Sub”).”

STAR EQUITY HOLDINGS, INC. entered into Bridgewater Loan Agreement with Bridgewater Bank valued at Loan with interest at 7.85%, principal payable May 20, 2029 (effective 2024-05-17).

“In connection with the completion of the Acquisition, on May 17, 2024, Timber Technologies Solutions, Inc., a wholly-owned subsidiary of the Company (the "Borrower"), entered into a Loan Agreement (the "Bridgewater Loan Agreement") with Bridgewater Bank ("Bridgewater") and issued a Term Promissory Note to Bridgewater thereunder (the "Facility").”

STAR EQUITY HOLDINGS, INC. entered into Asset Purchase Agreement with Timber Technologies, Inc. valued at up to $24.1 million (effective 2024-05-17).

“On May 17, 2024 (the "Closing Date"), Star Equity Holdings, Inc. (the "Company") entered into an asset purchase agreement (the "Purchase Agreement") with Timber Technologies, Inc. (the "Seller"), pursuant to which the Company acquired substantially all of the assets used in the business of the Seller and assumed certain liabilities of the Seller, as set forth in the Purchase Agreement (the "Acquisition").”

TSR INC entered into Agreement and Plan of Merger with Vienna Parent Corporation, Vienna Acquisition Corporation valued at Cash tender offer at $13.40 per share for all outstanding common stock of TSR, Inc.; aggregate princ (effective 2024-05-15).

“On May 15, 2024, Vienna Parent Corporation, an Indiana corporation (“ Parent ”), Vienna Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), and TSR, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”).”

WAFD INC entered into Agreement for Purchase and Sale of Loans with Bank of America, N.A. valued at $3.2 billion (effective 2024-05-14).

“On May 14, 2024 Washington Federal Bank, dba WaFd Bank, (“WaFd Bank”) a wholly owned subsidiary of WaFd, Inc. (the “Company”) entered into an Agreement for Purchase and Sale of Loans (the “Purchase Agreement”), with Bank of America, N.A. (the “Purchaser”) pursuant to which the Purchaser agreed to purchase approximately 2,000 commercial multi-family real estate loans (the “Loans”) from WaFd Bank (the “Transaction”) with a current aggregate unpaid principal balance of $3.2 billion.”

LABCORP HOLDINGS INC. entered into Guarantor Joinder Agreement with Bank of America, N.A. (effective 2024-05-17).

“On May 17, 2024, Labcorp Holdings entered into the Guarantor Joinder Agreement (the “Guarantor Joinder Agreement"), pursuant to which, among other things, Labcorp Holdings provided a full and unconditional guarantee of Labcorp’s obligations under the Third Amended and Restated Credit Agreement”

LABCORP HOLDINGS INC. entered into Seventeenth Supplemental Indenture with U.S. Bank Trust Company, National Association (effective 2024-05-17).

“on May 17, 2024, Labcorp, Labcorp Holdings and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a seventeenth supplemental indenture (the “Seventeenth Supplemental Indenture") to the indenture, dated as of November 19, 2010 between Labcorp and the Trustee”

LABCORP HOLDINGS INC. entered into Merger Agreement with Merger Sub (effective 2024-05-17).

“On May 17, 2024, Labcorp completed the Reorganization by implementing the Merger pursuant to the terms of the Merger Agreement.”

UGI CORP /PA/ entered into Fourth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, PNC Bank, National Association, as syndication agent, Citizens Bank, N.A., MUFG Bank Ltd. and Wells Fargo Bank, National Association, as co-documentation agents, JPMorgan Chase Bank, N.A., Citizens Bank, N.A., MUFG Bank Ltd., PNC Capital Markets LL valued at $300 million senior secured revolving credit facility (effective 2024-05-14).

“On May 14, 2024 (the “Effective Date”), UGI Energy Services, LLC (“UGIES”), a Pennsylvania limited liability company and an indirect, wholly owned subsidiary of UGI Corporation, entered into that certain Fourth Amended and Restated Credit Agreement (the “Revolving Credit Agreement”), by and among UGIES, JPMorgan Chase Bank, N.A., as administrative agent, PNC Bank, National Association, as syndication agent, Citizens Bank, N.A., MUFG Bank Ltd. and Wells Fargo Bank, National Association, as co-documentation agents, JPMorgan Chase Bank, N.A., Citizens Bank, N.A., MUFG Bank Ltd., PNC Capital Markets LLC and Wells Fargo Bank, National Association, as joint bookrunners and joint lead arrangers and the financial institutions from time to time party thereto as lenders (collectively, the “Lenders”).”

TETRA TECHNOLOGIES INC amended ABL Credit Agreement Amendment with Bank of America, N.A., as successor administrative agent, and each of the lenders and issuing banks party thereto valued at $80,000,000 to $100,000,000 (effective 2024-05-13).

“On May 13, 2024, TETRA Technologies, Inc., a Delaware corporation (“TETRA”), and certain of its subsidiaries entered into (i) an Agency Resignation, Appointment and Acceptance Agreement (the “Agency Resignation Agreement”) with JPMorgan Chase Bank, N.A., as resigning administrative agent (“JPM”), Bank of America, N.A., as successor administrative agent (“BofA”) and the lenders party thereto and (ii) an amendment (the “ABL Credit Agreement Amendment”) to the Credit Agreement dated as of September 10, 2018 (as previously amended, the “ABL Credit Agreement”), with BofA, as successor administrative agent, and each of the lenders and issuing banks party thereto.”

Vitro Biopharma, Inc. entered into senior secured convertible notes with accredited investors valued at aggregate principal amount of $375,000 (effective 2024-05-13).

“On May 13, 2024, Vitro BioPharma, Inc. (the “Company”) issued and sold to accredited investors, in a private placement, (i) senior secured convertible notes (the “Notes”) in the aggregate principal amount of $375,000”

DYCOM INDUSTRIES INC amended Amended and Restated Credit Agreement with Bank of America, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and other parties named therein (effective 2024-05-15).

“On May 15, 2024, Dycom Industries, Inc. (“Dycom”), the guarantors party thereto, the lenders named therein (the “Lenders”), Bank of America, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and other parties named therein amended and restated that certain Amended and Restated Credit Agreement, dated as of October 19, 2018 (as amended, the “Existing Credit Agreement”) in its entirety (the Existing Credit Agreement as so amended and restated, the “Amended and Restated Credit Agreement”).”

SUNation Energy, Inc. entered into Subscription Agreement with Lake Street Solar, LLC valued at $15 cash (effective 2024-05-13).

“On May 13, 2024, Pineapple Energy Inc. (the “Company”) entered into a Subscription and Investment Representation Agreement (the “Subscription Agreement”) with Lake Street Solar, LLC (the “Purchaser”), a former holder of more than ten percent of the Company’s common stock and an affiliate of Scott Honour, a director of the Company, pursuant to which the Company agreed to issue and sell one (1) share of the Company’s Series B Preferred Stock, par value $1.00 per share (the “Preferred Stock”), to the Purchaser for $15 cash.”

Signing Day Sports, Inc. entered into FirstFire Purchase Agreement with FirstFire Global Opportunities Fund, LLC valued at $412,500 (effective 2024-05-16).

“On May 16, 2024, Signing Day Sports, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement, dated as of May 16, 2024 (the “FirstFire Purchase Agreement”), with FirstFire Global Opportunities Fund, LLC (the “Investor”) pursuant to which the Company is required to issue the Investor a senior secured convertible promissory note with principal of $412,500”